Review



anti phospho n methyl d aspartate receptors subunit 2b nr2b tyr1472  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Cell Signaling Technology Inc anti phospho n methyl d aspartate receptors subunit 2b nr2b tyr1472
    Anti Phospho N Methyl D Aspartate Receptors Subunit 2b Nr2b Tyr1472, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 83 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/n+methyl+d+aspartate+receptor+subunit/Phospho-NMDA+Receptor+2B+(GluN2B)+(Tyr1472)+Antibody/pm41866450-70-30-40
    Average 93 stars, based on 83 article reviews
    anti phospho n methyl d aspartate receptors subunit 2b nr2b tyr1472 - by Bioz Stars, 2026-09
    93/100 stars

    Images

    Related Articles

    Blocking Assay:

    Article Title: Effects of Dexmedetomidine and Oxycodone on Neurocognitive and Inflammatory Response After Tourniquet-Induced Ischemia-Reperfusion Injury.
    Article Snippet: To evaluate the effects of dexmedetomidine (Dex) and oxycodone (Oxy) on neurocognitive and inflammatory response after tourniquet-induced ischemia–reperfusion (I/R) injury.. C57/BL6 mice were used to construct the mouse model of tourniquet-induced I/R injury.. Mice (n = 48) were randomly divided into sham, I/R, Dex or Oxy group.

    Membrane:

    Article Title: Effects of Dexmedetomidine and Oxycodone on Neurocognitive and Inflammatory Response After Tourniquet-Induced Ischemia-Reperfusion Injury.
    Article Snippet: To evaluate the effects of dexmedetomidine (Dex) and oxycodone (Oxy) on neurocognitive and inflammatory response after tourniquet-induced ischemia–reperfusion (I/R) injury.. C57/BL6 mice were used to construct the mouse model of tourniquet-induced I/R injury.. Mice (n = 48) were randomly divided into sham, I/R, Dex or Oxy group.

    Incubation:

    Article Title: Effects of Dexmedetomidine and Oxycodone on Neurocognitive and Inflammatory Response After Tourniquet-Induced Ischemia-Reperfusion Injury.
    Article Snippet: To evaluate the effects of dexmedetomidine (Dex) and oxycodone (Oxy) on neurocognitive and inflammatory response after tourniquet-induced ischemia–reperfusion (I/R) injury.. C57/BL6 mice were used to construct the mouse model of tourniquet-induced I/R injury.. Mice (n = 48) were randomly divided into sham, I/R, Dex or Oxy group.



    Similar Products

    90
    Thermo Fisher n-methyl-d-aspartate receptors (nmdar) antibody for nr1 subunit
    N Methyl D Aspartate Receptors (Nmdar) Antibody For Nr1 Subunit, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/n+methyl+d+aspartate+receptor+subunit/n+methyl+d+aspartate+receptors++nmdar++antibody+for+nr1+subunit/pm39724841-72-35-42
    Average 90 stars, based on 1 article reviews
    n-methyl-d-aspartate receptors (nmdar) antibody for nr1 subunit - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc anti phospho n methyl d aspartate receptors subunit 2b nr2b tyr1472
    Anti Phospho N Methyl D Aspartate Receptors Subunit 2b Nr2b Tyr1472, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/n+methyl+d+aspartate+receptor+subunit/Phospho-NMDA+Receptor+2B+(GluN2B)+(Tyr1472)+Antibody/pm41866450-70-30-40
    Average 93 stars, based on 1 article reviews
    anti phospho n methyl d aspartate receptors subunit 2b nr2b tyr1472 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    86
    Danaher Inc n methyl d aspartate receptor subunit r2b
    N Methyl D Aspartate Receptor Subunit R2b, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/n+methyl+d+aspartate+receptor+subunit/pmc10994667-71-44-49
    Average 86 stars, based on 1 article reviews
    n methyl d aspartate receptor subunit r2b - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc n-methyl d-aspartate acid receptor subunit 2a (nr2a
    N Methyl D Aspartate Acid Receptor Subunit 2a (Nr2a, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/n+methyl+d+aspartate+receptor+subunit/anti+nr2a/10__1155_slash_2024_slash_4784818-90-36-46
    Average 90 stars, based on 1 article reviews
    n-methyl d-aspartate acid receptor subunit 2a (nr2a - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Cusabio n-methyl-d-aspartic acid receptor (nmdar) subunit zeta-1 (glun1
    The x-axis in all panels marks the days since admission (Day 0 = admission day). Main treatment included an initial phase of four intravenous infusions of human γ-globulin (dose 25 g, indicated by 4 vertical dot-dash red lines). Simultaneously, glucocorticoid therapy was administered (represented by the green horizontal line above each subfigure, with the line’s width indicating the equivalent dose of methylprednisolone). Additionally, intrathecal methotrexate administration (dose 10 mg, represented by vertical solid yellow lines) and rituximab therapy (dose 100 mg, indicated by vertical long-dash blue lines) were administered. Clinical symptoms were assessed using two scales: (a) the Glasgow Coma Scale (GCS) and (b) the modified Rankin Scale (mRS), showing gradual improvement following treatment. Given the use of the immunotherapy, we measured the (c) percentage of CD19+ cells in the blood, assessed via flow cytometry, dropped to nearly non-existent levels by Day 10. We also monitored NMDAR-antigen (Ag) titres in the CSF. (d) A decrease in NMDAR-Ag titers in the CSF was observed as the treatment progressed. Given that anti-NMDA encephalitis is characterized by the presence of autoantibodies mainly against the NMDAR <t>GluN1</t> subunit, leading to NMDARs damage through internalization, shedding, and extracellular release, we also measured (e) The concentrations of GluN1 in CSF. As NMDARs are also present on the surface of astrocytes, we simultaneously measured the (f) concentrations of GluN1 in uADEVs (pg/per 1E+10 particles). As the trajectory of GluN1 in uADEVs was also a dynamic signal, composed of various wave components. Therefore, we conducted wavelet analysis using the Morlet wavelet as mother wavelet to identify and separate the significant components of this dynamic signal. (g) Wavelet analysis results of the log(10) GluN1 trajectory in uADEVs are presented, with colors representing power, black lines indicating the highest peak (ridge) in the respective region, and white areas representing significant components. Two significant components were identified, one with a short period (approximately 6-8 days) located below and another with a period of over 20 (the strongest ridge is at approximately 32 days). These two significant components were then reconstructed as follows: (h) The trajectory of the reconstructed significant short-period component (red line), and (i) the long-period component (approximately 32 days, the blue line). The gray dashed line in (h) and (i) represent the original log(10) trajectory (grey dashed lines).
    N Methyl D Aspartic Acid Receptor (Nmdar) Subunit Zeta 1 (Glun1, supplied by Cusabio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/n+methyl+d+aspartate+receptor+subunit/n+methyl+d+aspartic+acid+receptor++nmdar++subunit+zeta+1++glun1/med_rxiv__2024__01__12__24301104-82-0-26
    Average 90 stars, based on 1 article reviews
    n-methyl-d-aspartic acid receptor (nmdar) subunit zeta-1 (glun1 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    95
    Cell Signaling Technology Inc n methyl d aspartate receptor nmdar subunits glun2a
    Steamed PSPs ameliorate D-gal-induced hippocampal synaptic deficits. ( A – F ) The upper panels show representative blots of Arc/β-actin, GluA1/β-actin, GluA2/β-actin, <t>GluN2A/β-actin,</t> GluN2B/β-actin, p-GluN2B/GluN2B, and PSD95/β-actin, while the lower panel shows Arc/β-actin, GluA1/β-actin, GluA2/β-actin, GluN2A/β-actin, GluN2B/β-actin, p-GluN2B/GluN2B, and PSD95/β-actin quantification data ( n = 6). ( G ) Representative images of synaptic structure in hippocampal area CA1 (Magnification: ×5000). Red arrows indicate the synapses. ( H ) Number of synapses (12 μm 2 ) ( n = 5). Data are expressed as means ± SEM. * p < 0.05.
    N Methyl D Aspartate Receptor Nmdar Subunits Glun2a, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/n+methyl+d+aspartate+receptor+subunit/NMDA+Receptor+2A+(GluN2A)+Antibody/pmc09570032-248-89-95
    Average 95 stars, based on 1 article reviews
    n methyl d aspartate receptor nmdar subunits glun2a - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc n methyl d aspartate receptor subunit
    Steamed PSPs ameliorate D-gal-induced hippocampal synaptic deficits. ( A – F ) The upper panels show representative blots of Arc/β-actin, GluA1/β-actin, GluA2/β-actin, <t>GluN2A/β-actin,</t> GluN2B/β-actin, p-GluN2B/GluN2B, and PSD95/β-actin, while the lower panel shows Arc/β-actin, GluA1/β-actin, GluA2/β-actin, GluN2A/β-actin, GluN2B/β-actin, p-GluN2B/GluN2B, and PSD95/β-actin quantification data ( n = 6). ( G ) Representative images of synaptic structure in hippocampal area CA1 (Magnification: ×5000). Red arrows indicate the synapses. ( H ) Number of synapses (12 μm 2 ) ( n = 5). Data are expressed as means ± SEM. * p < 0.05.
    N Methyl D Aspartate Receptor Subunit, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/n+methyl+d+aspartate+receptor+subunit/NMDA+Receptor+2B+(GluN2B)+Rabbit+mAb/pm34625874-62-60-66
    Average 94 stars, based on 1 article reviews
    n methyl d aspartate receptor subunit - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    90
    Jackson Laboratory n-methyl d-aspartate glutamate receptor, subunit 2a knockdown mice (grin2atm1nak)
    Steamed PSPs ameliorate D-gal-induced hippocampal synaptic deficits. ( A – F ) The upper panels show representative blots of Arc/β-actin, GluA1/β-actin, GluA2/β-actin, <t>GluN2A/β-actin,</t> GluN2B/β-actin, p-GluN2B/GluN2B, and PSD95/β-actin, while the lower panel shows Arc/β-actin, GluA1/β-actin, GluA2/β-actin, GluN2A/β-actin, GluN2B/β-actin, p-GluN2B/GluN2B, and PSD95/β-actin quantification data ( n = 6). ( G ) Representative images of synaptic structure in hippocampal area CA1 (Magnification: ×5000). Red arrows indicate the synapses. ( H ) Number of synapses (12 μm 2 ) ( n = 5). Data are expressed as means ± SEM. * p < 0.05.
    N Methyl D Aspartate Glutamate Receptor, Subunit 2a Knockdown Mice (Grin2atm1nak), supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/n+methyl+d+aspartate+receptor+subunit/glun2a+knockout++ko++male+mice+with+null+mutation+for+the+glun2a+coding+gene+grin2a/pm34142063-190-6-13
    Average 90 stars, based on 1 article reviews
    n-methyl d-aspartate glutamate receptor, subunit 2a knockdown mice (grin2atm1nak) - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Dawley Inc n-methyl-d-aspartate receptor nmdar1-1a subunit (nr1)
    Steamed PSPs ameliorate D-gal-induced hippocampal synaptic deficits. ( A – F ) The upper panels show representative blots of Arc/β-actin, GluA1/β-actin, GluA2/β-actin, <t>GluN2A/β-actin,</t> GluN2B/β-actin, p-GluN2B/GluN2B, and PSD95/β-actin, while the lower panel shows Arc/β-actin, GluA1/β-actin, GluA2/β-actin, GluN2A/β-actin, GluN2B/β-actin, p-GluN2B/GluN2B, and PSD95/β-actin quantification data ( n = 6). ( G ) Representative images of synaptic structure in hippocampal area CA1 (Magnification: ×5000). Red arrows indicate the synapses. ( H ) Number of synapses (12 μm 2 ) ( n = 5). Data are expressed as means ± SEM. * p < 0.05.
    N Methyl D Aspartate Receptor Nmdar1 1a Subunit (Nr1), supplied by Dawley Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/n+methyl+d+aspartate+receptor+subunit/n+methyl+d+aspartate+receptor+nmdar1+1a+subunit++nr1+/pm33739808-190-1-3
    Average 90 stars, based on 1 article reviews
    n-methyl-d-aspartate receptor nmdar1-1a subunit (nr1) - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Jackson Laboratory n-methyl d-aspartate glutamate receptor, subunit 2a knockdown mice grin2a tm1nak
    Steamed PSPs ameliorate D-gal-induced hippocampal synaptic deficits. ( A – F ) The upper panels show representative blots of Arc/β-actin, GluA1/β-actin, GluA2/β-actin, <t>GluN2A/β-actin,</t> GluN2B/β-actin, p-GluN2B/GluN2B, and PSD95/β-actin, while the lower panel shows Arc/β-actin, GluA1/β-actin, GluA2/β-actin, GluN2A/β-actin, GluN2B/β-actin, p-GluN2B/GluN2B, and PSD95/β-actin quantification data ( n = 6). ( G ) Representative images of synaptic structure in hippocampal area CA1 (Magnification: ×5000). Red arrows indicate the synapses. ( H ) Number of synapses (12 μm 2 ) ( n = 5). Data are expressed as means ± SEM. * p < 0.05.
    N Methyl D Aspartate Glutamate Receptor, Subunit 2a Knockdown Mice Grin2a Tm1nak, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/n+methyl+d+aspartate+receptor+subunit/glun2a+knockout++ko++male+mice+with+null+mutation+for+the+glun2a+coding+gene+grin2a/pmc08185192-276-6-17
    Average 90 stars, based on 1 article reviews
    n-methyl d-aspartate glutamate receptor, subunit 2a knockdown mice grin2a tm1nak - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    The x-axis in all panels marks the days since admission (Day 0 = admission day). Main treatment included an initial phase of four intravenous infusions of human γ-globulin (dose 25 g, indicated by 4 vertical dot-dash red lines). Simultaneously, glucocorticoid therapy was administered (represented by the green horizontal line above each subfigure, with the line’s width indicating the equivalent dose of methylprednisolone). Additionally, intrathecal methotrexate administration (dose 10 mg, represented by vertical solid yellow lines) and rituximab therapy (dose 100 mg, indicated by vertical long-dash blue lines) were administered. Clinical symptoms were assessed using two scales: (a) the Glasgow Coma Scale (GCS) and (b) the modified Rankin Scale (mRS), showing gradual improvement following treatment. Given the use of the immunotherapy, we measured the (c) percentage of CD19+ cells in the blood, assessed via flow cytometry, dropped to nearly non-existent levels by Day 10. We also monitored NMDAR-antigen (Ag) titres in the CSF. (d) A decrease in NMDAR-Ag titers in the CSF was observed as the treatment progressed. Given that anti-NMDA encephalitis is characterized by the presence of autoantibodies mainly against the NMDAR GluN1 subunit, leading to NMDARs damage through internalization, shedding, and extracellular release, we also measured (e) The concentrations of GluN1 in CSF. As NMDARs are also present on the surface of astrocytes, we simultaneously measured the (f) concentrations of GluN1 in uADEVs (pg/per 1E+10 particles). As the trajectory of GluN1 in uADEVs was also a dynamic signal, composed of various wave components. Therefore, we conducted wavelet analysis using the Morlet wavelet as mother wavelet to identify and separate the significant components of this dynamic signal. (g) Wavelet analysis results of the log(10) GluN1 trajectory in uADEVs are presented, with colors representing power, black lines indicating the highest peak (ridge) in the respective region, and white areas representing significant components. Two significant components were identified, one with a short period (approximately 6-8 days) located below and another with a period of over 20 (the strongest ridge is at approximately 32 days). These two significant components were then reconstructed as follows: (h) The trajectory of the reconstructed significant short-period component (red line), and (i) the long-period component (approximately 32 days, the blue line). The gray dashed line in (h) and (i) represent the original log(10) trajectory (grey dashed lines).

    Journal: medRxiv

    Article Title: Urinary Astrocyte-derived Extracellular Vesicles: A Non-invasive Tool for Capturing Human In Vivo Molecular “Movies” of Brain

    doi: 10.1101/2024.01.12.24301104

    Figure Lengend Snippet: The x-axis in all panels marks the days since admission (Day 0 = admission day). Main treatment included an initial phase of four intravenous infusions of human γ-globulin (dose 25 g, indicated by 4 vertical dot-dash red lines). Simultaneously, glucocorticoid therapy was administered (represented by the green horizontal line above each subfigure, with the line’s width indicating the equivalent dose of methylprednisolone). Additionally, intrathecal methotrexate administration (dose 10 mg, represented by vertical solid yellow lines) and rituximab therapy (dose 100 mg, indicated by vertical long-dash blue lines) were administered. Clinical symptoms were assessed using two scales: (a) the Glasgow Coma Scale (GCS) and (b) the modified Rankin Scale (mRS), showing gradual improvement following treatment. Given the use of the immunotherapy, we measured the (c) percentage of CD19+ cells in the blood, assessed via flow cytometry, dropped to nearly non-existent levels by Day 10. We also monitored NMDAR-antigen (Ag) titres in the CSF. (d) A decrease in NMDAR-Ag titers in the CSF was observed as the treatment progressed. Given that anti-NMDA encephalitis is characterized by the presence of autoantibodies mainly against the NMDAR GluN1 subunit, leading to NMDARs damage through internalization, shedding, and extracellular release, we also measured (e) The concentrations of GluN1 in CSF. As NMDARs are also present on the surface of astrocytes, we simultaneously measured the (f) concentrations of GluN1 in uADEVs (pg/per 1E+10 particles). As the trajectory of GluN1 in uADEVs was also a dynamic signal, composed of various wave components. Therefore, we conducted wavelet analysis using the Morlet wavelet as mother wavelet to identify and separate the significant components of this dynamic signal. (g) Wavelet analysis results of the log(10) GluN1 trajectory in uADEVs are presented, with colors representing power, black lines indicating the highest peak (ridge) in the respective region, and white areas representing significant components. Two significant components were identified, one with a short period (approximately 6-8 days) located below and another with a period of over 20 (the strongest ridge is at approximately 32 days). These two significant components were then reconstructed as follows: (h) The trajectory of the reconstructed significant short-period component (red line), and (i) the long-period component (approximately 32 days, the blue line). The gray dashed line in (h) and (i) represent the original log(10) trajectory (grey dashed lines).

    Article Snippet: N-methyl-d-aspartic acid receptor (NMDAR) subunit zeta-1 (GluN1), the pathogenic molecule in anti-NMDAR encephalitis, was measured in CSF and uADEV samples using the enzyme-linked immunosorbent assay (ELISA) (CUSABIO, Catalog# CSB-EL009911HU).

    Techniques: Modification, Flow Cytometry

    Steamed PSPs ameliorate D-gal-induced hippocampal synaptic deficits. ( A – F ) The upper panels show representative blots of Arc/β-actin, GluA1/β-actin, GluA2/β-actin, GluN2A/β-actin, GluN2B/β-actin, p-GluN2B/GluN2B, and PSD95/β-actin, while the lower panel shows Arc/β-actin, GluA1/β-actin, GluA2/β-actin, GluN2A/β-actin, GluN2B/β-actin, p-GluN2B/GluN2B, and PSD95/β-actin quantification data ( n = 6). ( G ) Representative images of synaptic structure in hippocampal area CA1 (Magnification: ×5000). Red arrows indicate the synapses. ( H ) Number of synapses (12 μm 2 ) ( n = 5). Data are expressed as means ± SEM. * p < 0.05.

    Journal: International Journal of Molecular Sciences

    Article Title: Use of Steaming Process to Improve Biochemical Activity of Polygonatum sibiricum Polysaccharides against D-Galactose-Induced Memory Impairment in Mice

    doi: 10.3390/ijms231911220

    Figure Lengend Snippet: Steamed PSPs ameliorate D-gal-induced hippocampal synaptic deficits. ( A – F ) The upper panels show representative blots of Arc/β-actin, GluA1/β-actin, GluA2/β-actin, GluN2A/β-actin, GluN2B/β-actin, p-GluN2B/GluN2B, and PSD95/β-actin, while the lower panel shows Arc/β-actin, GluA1/β-actin, GluA2/β-actin, GluN2A/β-actin, GluN2B/β-actin, p-GluN2B/GluN2B, and PSD95/β-actin quantification data ( n = 6). ( G ) Representative images of synaptic structure in hippocampal area CA1 (Magnification: ×5000). Red arrows indicate the synapses. ( H ) Number of synapses (12 μm 2 ) ( n = 5). Data are expressed as means ± SEM. * p < 0.05.

    Article Snippet: Thereafter, protein samples were separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis at 75 V for 15 min, followed by 115 V for 75 min before transferring at 300 mA onto a nitrocellulose membrane for 2 h. Membranes were blocked with 5% skim milk (dissolved in PBS containing 0.1% Tween-20) for 2 h at room temperature, washed three times with PBS for 10 min each, then incubated at 4 °C overnight in primary antibody against the α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor (AMPAR) subunits GluA1 (1:1000, CST) and GluA2 (1:1000, CST), the N-methyl-D-aspartate receptor (NMDAR) subunits GluN2A (1:1000, CST), GluN2B (1:1000, CST), and p-GluN2B (1:1000, CST), nuclear factor-erythroid factor 2-related factor 2 (Nrf2, 1:1000, ZEN BIO), heme oxygenase-1 (HO-1, 1:1000, ZEN BIO), NOD-like receptor protein 3 (NLRP3, 1:1000, CST), apoptosis-associated speck like protein (ASC, 1:1000, ZEN BIO), postsynaptic density protein 95 (PSD95, 1:1000, CST), activity-regulated cytoskeletal protein (Arc, 1:1000, Synaptic Systems), and β-actin (1:1000, CST).

    Techniques: